Search
Search
About
Log in
Join
Experiences with
Lymphomas
Posts
Communities
783 public posts
Filter results
Stem cell transplants
This was on the ACOR list today. I found it fascinating. Jeff "Date: Thu, 11 Jun 2015 06:51:53 -0500 From: Dennis Pinkard <pinkardd@CHARTER.NET> Subject: Researchers identify patients at risk for stem cell transplant complications Phase 2 clinical trial. http://www.sciencedaily.com/releases
This was on the ACOR list today. I found it fascinating. Jeff "Date: Thu, 11 Jun 2015 06:51:53 -0500 From: Dennis Pinkard <pinkardd@CHARTER.NET> Subject: Researchers identify patients at risk for stem cell transplant complications Phase 2 clinical trial. http://www.sciencedaily.com/releases
Justasheet1
in
CLL Support
9 years ago
Langerhans cell histiocytosis
These diseases are related to other forms of abnormal proliferation of white blood cells, such as leukemias and
lymphomas
.
These diseases are related to other forms of abnormal proliferation of white blood cells, such as leukemias and
lymphomas
.
winterrose-23
in
Lung Conditions Community Forum
9 years ago
I'm rare
These diseases are related to other forms of abnormal proliferation of white blood cells, such as leukemias and
lymphomas
. has anyone here got this ?
These diseases are related to other forms of abnormal proliferation of white blood cells, such as leukemias and
lymphomas
. has anyone here got this ?
winterrose-23
in
The Roy Castle Lung Cancer Foundation
9 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Vigorous physical activity may lower risk of NHL
CLL/SLL is classified as one of the many Non Hodgkin's
Lymphomas
(NHL), so I was interested to read that people that engage in vigorous physical activity may have a lower risk of developing NHL: http://www.hematologytimes.com/p_article.do?
CLL/SLL is classified as one of the many Non Hodgkin's
Lymphomas
(NHL), so I was interested to read that people that engage in vigorous physical activity may have a lower risk of developing NHL: http://www.hematologytimes.com/p_article.do?
AussieNeil
Partner
in
CLL Support
9 years ago
Large B Cell lymphoma and Grave Disease
I have read that thyroid disease is a B cell auto immune disorder and am wondering if there is a link? I beat lymphoma and two years into remission am told I may have Graves. Little nervous...
I have read that thyroid disease is a B cell auto immune disorder and am wondering if there is a link? I beat lymphoma and two years into remission am told I may have Graves. Little nervous...
suky58
in
Lymphoma Canada
9 years ago
Novel Biologic Agents for Non-HL and CLL — Part 2: Adoptive Cellular Immunotherapy, Small-Molecule Inhibitors, and Immunomodulation
Instead, the focus is on the abundance of exciting new biologic and targeted agents that are bulldozing the therapeutic landscape in the
lymphomas
and chronic lymphocytic leukemia, with many of these new agents in oral form and most well-tolerated."
Instead, the focus is on the abundance of exciting new biologic and targeted agents that are bulldozing the therapeutic landscape in the
lymphomas
and chronic lymphocytic leukemia, with many of these new agents in oral form and most well-tolerated."
AussieNeil
Partner
in
CLL Support
9 years ago
DLBCL articles from April 2015 Hematology Times
“Unfortunately, these
lymphomas
are morphologically undistinguishable in routine diagnosis, which is a major problem for the development of targeted therapies.
“Unfortunately, these
lymphomas
are morphologically undistinguishable in routine diagnosis, which is a major problem for the development of targeted therapies.
AussieNeil
Partner
in
CLL Support
9 years ago
Blood counts from 11-th may
Hy everyone, My last results :WBC 67.1;LYM 87%;ALC 58;Hb 12.7;PLT 233;only one aria with swollen lymph node (the right size of my neck), small skin infections. My Doc said to prepare for treatment, and ask me my opinion about a monotherapy with Rithuximab.Please yours comments. Thanks all for a prompt
Hy everyone, My last results :WBC 67.1;LYM 87%;ALC 58;Hb 12.7;PLT 233;only one aria with swollen lymph node (the right size of my neck), small skin infections. My Doc said to prepare for treatment, and ask me my opinion about a monotherapy with Rithuximab.Please yours comments. Thanks all for a prompt
lilica955
in
CLL Support
9 years ago
It’s Time to Tackle the Evidence Gap in Lymphoid Cancers - Ahmad Halwani, MD
Ahmad Halwani, Assistant Professor, Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah Healthcare, Salt Lake City, USA, examines the [i]"mostly unmet need for research that aims to further our understanding of the comparative effectiveness of cancer treatments
Ahmad Halwani, Assistant Professor, Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah Healthcare, Salt Lake City, USA, examines the [i]"mostly unmet need for research that aims to further our understanding of the comparative effectiveness of cancer treatments
AussieNeil
Partner
in
CLL Support
9 years ago
HODGKINS LYMPHOMA DISEASE (STAGE IV AES)
HI, NAMASTHE SIR/MADAM My wife has under gone Chemotherphy (ABVD) 5th cycle on 20.04.15. 6th cycle is proposed on 5th May,2015. Yesterday Blood test was carried out i.e. CBP with ESR, Serum creatinine, serum Bilirubin. 5th cycle was done on 20.04.2015. At that time Blood report i.e. CBP with ESR
HI, NAMASTHE SIR/MADAM My wife has under gone Chemotherphy (ABVD) 5th cycle on 20.04.15. 6th cycle is proposed on 5th May,2015. Yesterday Blood test was carried out i.e. CBP with ESR, Serum creatinine, serum Bilirubin. 5th cycle was done on 20.04.2015. At that time Blood report i.e. CBP with ESR
babu57
in
Breast Cancer India
9 years ago
Hematologic Cancer Drugs
Good reference for Leukemias,
lymphomas
, and other hematologic cancer drugs approved in U.S. http://www.cancertherapyadvisor.com/leukemias-
lymphomas
-and-other-hematologic-cancers/category/161/0/?
Good reference for Leukemias,
lymphomas
, and other hematologic cancer drugs approved in U.S. http://www.cancertherapyadvisor.com/leukemias-
lymphomas
-and-other-hematologic-cancers/category/161/0/?
shazie
in
CLL Support
9 years ago
Itchy bumps on skin
Trouble is we are testing for secondary cancer/skin lymphoma and these tests are so specific as there are many skin
lymphomas
all with their own detection tests. Any ideas out there? ? Desperate and itchy!!!!
Trouble is we are testing for secondary cancer/skin lymphoma and these tests are so specific as there are many skin
lymphomas
all with their own detection tests. Any ideas out there? ? Desperate and itchy!!!!
timboyce
in
CLL Support
9 years ago
Post Chemo Effects
Hi. Can somebody out there give me some help? I finished my chemo treatment - Bendamustine & Rituximab - in February and I'm delighted that it was successful although my white cell count is still low. But the problem I have is that for the last couple of months I have, especially in the evenings, what
Hi. Can somebody out there give me some help? I finished my chemo treatment - Bendamustine & Rituximab - in February and I'm delighted that it was successful although my white cell count is still low. But the problem I have is that for the last couple of months I have, especially in the evenings, what
jaypax
in
CLL Support
9 years ago
Encouraging progress on CAR-T therapy
[i]"Since CD19 is found on the cell surface in most leukemias and
lymphomas
, but nowhere else in the body except for B-lineage cells, it is an attractive target for therapy.
[i]"Since CD19 is found on the cell surface in most leukemias and
lymphomas
, but nowhere else in the body except for B-lineage cells, it is an attractive target for therapy.
AussieNeil
Partner
in
CLL Support
9 years ago
Assessing Response With Novel Agents in CLL - OncLive Peer Exchange
While this peer review may be over technical for many, it does provide an insight into how the new CLL drugs are challenging the established methods of assessing treatment effectiveness. Panelists:- Myron S. Czuczman, MD, Roswell Park; John C. Byrd, MD, Ohio State; Richard Furman, MD, Weill Cornell;
While this peer review may be over technical for many, it does provide an insight into how the new CLL drugs are challenging the established methods of assessing treatment effectiveness. Panelists:- Myron S. Czuczman, MD, Roswell Park; John C. Byrd, MD, Ohio State; Richard Furman, MD, Weill Cornell;
AussieNeil
Partner
in
CLL Support
9 years ago
More evidence on how exercise shapes our destiny
Not CLL related, but more evidence that exercise shapes our bodies and our health. Analysis of baseline fitness data from a study of nearly 14,000 men compiled between 1971 and 2009, and lung, prostate, and colorectal cancer diagnoses and outcomes using Medicare data from 1999 to 2009, showed that improved
Not CLL related, but more evidence that exercise shapes our bodies and our health. Analysis of baseline fitness data from a study of nearly 14,000 men compiled between 1971 and 2009, and lung, prostate, and colorectal cancer diagnoses and outcomes using Medicare data from 1999 to 2009, showed that improved
AussieNeil
Partner
in
CLL Support
9 years ago
Fitbit
I finished treatment for Hodgkins Lymphoma in 2012. I gained quite a bit of weight during treatment, largely from the steroids and being significantly less active. A few years out of treatment and I am still working to get back to my fitness levels from before diagnosis. I've recently invested in
I finished treatment for Hodgkins Lymphoma in 2012. I gained quite a bit of weight during treatment, largely from the steroids and being significantly less active. A few years out of treatment and I am still working to get back to my fitness levels from before diagnosis. I've recently invested in
arkleins
in
Lymphoma Canada
9 years ago
Anisina works with standard chemo to kill cancer cells 20 times faster
[i]"Novogen today has announced that one of its oncology pipeline drug candidates, Anisina (ATM-3507), has achieved a major milestone in its development, confirming the concept that comprehensive destruction of a cancer cell’s cytoskeleton can deliver a powerful anti-cancer effect. : Anisina was developed
[i]"Novogen today has announced that one of its oncology pipeline drug candidates, Anisina (ATM-3507), has achieved a major milestone in its development, confirming the concept that comprehensive destruction of a cancer cell’s cytoskeleton can deliver a powerful anti-cancer effect. : Anisina was developed
AussieNeil
Partner
in
CLL Support
9 years ago
Diptheria Immunotoxin Effectively Targets B-Cell Malignancies - Phase 1 trial of DT2219
[i]"Dr. Vallera and colleagues enrolled 25 chemo-refractory patients with previously treated pre-B acute lymphoblastic leukemia, chronic lymphocytic leukemia, or non-Hodgkin lymphoma whose tumors expressed CD19 and/or CD22. Eight patients had previously undergone unsuccessful bone marrow transplantations
[i]"Dr. Vallera and colleagues enrolled 25 chemo-refractory patients with previously treated pre-B acute lymphoblastic leukemia, chronic lymphocytic leukemia, or non-Hodgkin lymphoma whose tumors expressed CD19 and/or CD22. Eight patients had previously undergone unsuccessful bone marrow transplantations
AussieNeil
Partner
in
CLL Support
9 years ago
NCI Director Resigns
NCI Director Harold Varmus Resigns Author: Silas Inman Dr. Harold Varmus Harold Varmus, MD The Nobel Prize winning director of the National Cancer Institute (NCI), Harold Varmus, MD, has tendered his resignation in a letter to President Barack Obama, citing economic restraints as a leading cause for
NCI Director Harold Varmus Resigns Author: Silas Inman Dr. Harold Varmus Harold Varmus, MD The Nobel Prize winning director of the National Cancer Institute (NCI), Harold Varmus, MD, has tendered his resignation in a letter to President Barack Obama, citing economic restraints as a leading cause for
Justasheet1
in
CLL Support
9 years ago
1
...
31
32
33
...
40
Next page
10
20
30
40
Filter results
Clear filters
Posted in
All communities
CLL Support
471 results
Non Hodgkin's Lymphoma Friends
117 results
Lymphoma Canada
34 results
View top 10 communities
Sort by
Most Relevant
Newest